Reliance Industries Ltd's net profit is expected to rise 11 percent from a year earlier to about Rs 18,450 crore for the July-September quarter.
Asian Paints is anticipated to deliver a weak performance in the first quarter of FY2026, amid slowing urban consumption and increased competition.
The standalone commercial vehicle (CV) business is expected to report a 5 percent year-on-year decline in revenue, while the passenger vehicle (PV) segment may see a high single-digit drop.
Axis Bank shares fell over four percent despite reporting an estimate-beating net profit of Rs 7,118 crore for the quarter ended March FY2025.
Brokerages were optimistic on Tata Consumer Products' margin recovery prospects amid normalising input cost inflation.
Adani Ports is set to report steady earnings growth, supported by strong container and liquid cargo volumes, as well as contributions from recent acquisitions. Despite headwinds in iron ore and coal cargo, efficiency and expansion efforts are expected to drive profitability.
Bajaj Finance Q3 Results Preview. The NBFC is likely to deliver robust earnings, driven by strong AUM growth and stabilising margins. However, rising credit costs and slight asset quality pressures are expected to draw attention.
SBI Life Q3 Results Preview: SBI Life’s Q3 FY25 APE is expected to grow 6.5 percent, but VNB margin may contract 90 basis points due to regulatory changes and higher ULIPs in the product mix.
While earnings forecasts for Apollo Hospitals varies across a vast range of 33 percent, a common thread tying all brokerage expectations is that of the company delivering robust net profit growth in the September quarter.
Steady US sales may provide some support, but rising R&D costs and operational expenses are expected to weigh on Dr Reddy’s margins, likely impacting net profit in Q2.
The power company is also estimated to report a EBITDA margin of around 19.2 percent, marginally down from 19.6 percent in the corresponding quarter of the previous fiscal, as per the average of four brokerages.
After a stellar FY24, earnings growth for Cipla is expected to moderate as the launch of major high-margin drugs in the US generics market loses steam amid regulatory hurdles.
India's largest drugmaker--Sun Pharma is expected to deliver one of the strongest earnings growth among peers in Q2, aided by double-digit growth in specialty sales, outperformance in the Indian pharma market and increased Revlimid contribution.
According to a Moneycontrol poll of seven brokerages, Hindustan Unilever is likely to report a revenue growth higher by 4.4 percent on-year, at Rs 15,694 crore.
Net Interest Margins are likely to remain stable on a sequential basis with a positive bias
Nestle India’s growth in recent quarters has been pricing-led, and some brokerages expect this trend to continue during the quarter ended September.
Investors will likely focus on Reliance Jio’s ARPU growth and growth in the retail segment in Q2 FY25 earnings report.
Grasim Industries' Q1FY25 earnings are likely to be impacted by losses from its new paints division, rising interest and depreciation costs, and mixed performance across core segments.
Net profit is also expected to grow to Rs 4,028.2 crore in the quarter ending June 2024 from Rs 3,382.8 crore in the quarter ending June 2023.
Net revenue, however, is likely to fall 37.3 percent to Rs 5,000 crore in the June quarter.
According to the average of 10 estimates compiled by Moneycontrol, Tech Mahindra's net profit is projected to increase over 30 percent quarter-over-quarter, reaching Rs 861 crore in Q1 FY25.
According to a Moneycontrol poll of eight brokerages, the Maggi-maker is likely to report an eight percent jump in revenue at Rs 5,060 crore.
HUL noted it was seeing recovery in rural demand while continuing to focus on its premium portfolio, and its market-share is also expected to improve in the medium term.
The heatwave, price cuts and stable commodity prices are expected to result in the FMCG giant seeing flat earnings.
Infosys large deal wins were highest ever at 34 with TCV of $4.1 billion, with 57.6% being net new.